Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients

ClinicalTrials.gov ID: NCT02461602

Public ClinicalTrials.gov record NCT02461602. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 11:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

ELITE (Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients) is a two year research project to assess warfarin management issues faced by atrial fibrillation (AF) patients in ambulatory settings.

Study identification

NCT ID
NCT02461602
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Duke University
Other
Enrollment
251 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2016
Primary completion
May 30, 2018
Completion
May 30, 2018
Last update posted
Apr 8, 2019

2016 – 2018

United States locations

U.S. sites
21
U.S. states
16
U.S. cities
21
Facility City State ZIP Site status
Foothill Cardiology Pasadena California 91105
Holy Cross Medical Group Coral Springs Florida 33065
Charlotte Heart Group Port Charlotte Florida 33952
Atlanta Institute for Medical Research, Inc. Atlanta Georgia 30350
Atlanta Heart Specialists Cumming Georgia 30041
Cardiovascular Research of Northwest Indiana, L.L.C. Munster Indiana 46321
Research Integrity, LLC. Owensboro Kentucky 42303
Ochsner Health System New Orleans Louisiana 70121
Penobscot Bay Medical Center Rockport Maine 04856
Endeavor Medical Research Alpena Michigan 49707
Great Lakes Heart and Vascular Institute Saint Joseph Michigan 49085
HealthEast Medical Research Institute Saint Paul Minnesota 55102
Jackson Heart Clinic Jackson Mississippi 39216
Cardiovascular Associates of the Delaware Valley Elmer New Jersey 08318
Lourdes Cardiology Services Voorhees Township New Jersey 08043
Duke Cardiology of Lumberton Lumberton North Carolina 28358
Doylestown Health Cardiology Doylestown Pennsylvania 18901
Columbia Heart Clinic, PA Columbia South Carolina 29203
North Texas Research Associates Allen Texas 75013
Providence Health Center Waco Texas 76712
Riverside Cardiology Specialists Newport News Virginia 23601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02461602, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2019 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02461602 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →